This brand name is authorized in Hong Kong, New Zealand
The drug DIFFLAM-C contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Benzydamine
UNII K2GI407R4Q - BENZYDAMINE HYDROCHLORIDE
|
|
Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis. |
|
2
Chlorhexidine
UNII MOR84MUD8E - CHLORHEXIDINE GLUCONATE
|
|
Chlorhexidine is an antimicrobial agent, active against a broad spectrum of Gram-positive and Gram-negative organisms, yeasts, fungi, opportunistic anaerobes and aerobes. Chlorhexidine is mainly a “membrane-acting” agent that destroys the outer membrane of the bacteria. It is inactive on bacterial spores unless the temperatures are high. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: HK | Department of Health Drug Office | Identifier(s): 39911 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 7201 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
